LENSAR (NASDAQ:LNSR – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, August 8th.
LENSAR (NASDAQ:LNSR – Get Free Report) last announced its earnings results on Thursday, May 9th. The company reported ($0.19) earnings per share (EPS) for the quarter. The firm had revenue of $10.59 million during the quarter. LENSAR had a negative net margin of 27.57% and a negative return on equity of 36.53%.
LENSAR Stock Up 4.2 %
LNSR traded up $0.21 on Friday, hitting $5.20. 18,157 shares of the company traded hands, compared to its average volume of 19,607. The company has a 50 day moving average of $4.69 and a 200-day moving average of $4.13. The stock has a market capitalization of $59.28 million, a PE ratio of -3.29 and a beta of 0.65. LENSAR has a 12-month low of $1.80 and a 12-month high of $5.60.
About LENSAR
LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
Featured Stories
- Five stocks we like better than LENSAR
- Compound Interest and Why It Matters When Investing
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- P/E Ratio Calculation: How to Assess Stocks
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
- How is Compound Interest Calculated?
- Chevron Stock Dips as Earnings Miss Highlights Merger Uncertainty
Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.